Surfactant Replacement Therapy for Respiratory Distress Syndrome
Open Access
- 1 March 1999
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 103 (3) , 684-685
- https://doi.org/10.1542/peds.103.3.684
Abstract
Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and mortality in low birth weight immature infants. Surfactant therapy substantially reduces mortality and respiratory morbidity for this population. The statement summarizes the indications for surfactant replacement therapy. Because respiratory insufficiency may be a component of multiorgan dysfunction in sick infants, surfactant should be administered only at institutions with qualified personnel and facilities for the comprehensive care of sick infants.Keywords
This publication has 23 references indexed in Scilit:
- A Multicenter Randomized Masked Comparison Trial of Synthetic Surfactant Versus Calf Lung Surfactant Extract in the Prevention of Neonatal Respiratory Distress SyndromePediatrics, 1997
- Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactantThe Journal of Pediatrics, 1995
- One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placeboThe Journal of Pediatrics, 1995
- Survival and follow-up of infants born at 23 to 26 weeks of gestational age: Effects of surfactant therapyThe Journal of Pediatrics, 1994
- A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndromeThe Journal of Pediatrics, 1993
- A Controlled Trial of Synthetic Surfactant in Infants Weighing 1250 G or More with Respiratory Distress SyndromeNew England Journal of Medicine, 1991
- Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndromeThe Journal of Pediatrics, 1991
- Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturityThe Journal of Pediatrics, 1991
- A Comparison of Surfactant as Immediate Prophylaxis and as Rescue Therapy in Newborns of Less Than 30 Weeks' GestationNew England Journal of Medicine, 1991
- Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trialThe Journal of Pediatrics, 1991